Expand CUE Menu
CUE MENU

CUE Latest Press Releases

-- August 24, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE) PRNewswire 9:05 AM

-- August 14, 2026 --

Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM

-- August 3, 2026 --

Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission Globe Newswire 8:30 AM

-- July 13, 2026 --

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development Globe Newswire 8:30 AM

-- July 9, 2026 --

Cue Biopharma Announces $50.0 Million Private Placement Globe Newswire 9:40 PM

-- June 2, 2026 --

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution Globe Newswire 4:05 PM

-- May 21, 2026 --

Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 4:05 PM

-- May 14, 2026 --

Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments Globe Newswire 4:07 PM

-- May 7, 2026 --

Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:07 PM

-- April 30, 2026 --

Cue Biopharma Announces $30 Million Private Placement Globe Newswire 4:25 PM
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody Globe Newswire 4:15 PM
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company Globe Newswire 4:05 PM

-- April 22, 2026 --

Cue Biopharma Announces 1-for-30 Reverse Stock Split Globe Newswire 8:37 AM

-- April 15, 2026 --

Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026 Globe Newswire 8:00 AM

-- April 8, 2026 --

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes